Diagnostic accuracy of coronary computed tomography angiography-derived fractional flow reserve.


Journal

Biomedical engineering online
ISSN: 1475-925X
Titre abrégé: Biomed Eng Online
Pays: England
ID NLM: 101147518

Informations de publication

Date de publication:
04 Aug 2021
Historique:
received: 05 05 2021
accepted: 26 07 2021
entrez: 5 8 2021
pubmed: 6 8 2021
medline: 15 12 2021
Statut: epublish

Résumé

Fractional flow reserve (FFR) is a widely used gold standard to evaluate ischemia-causing lesions. A new method of non-invasive approach, termed as AccuFFRct, for calculating FFR based on coronary computed tomography angiography (CCTA) and computational fluid dynamics (CFD) has been proposed. However, its diagnostic accuracy has not been validated. This study sought to present a novel approach for non-invasive computation of FFR and evaluate its diagnostic performance in patients with coronary stenosis. A total of 54 consecutive patients with 78 vessels from a single center who underwent CCTA and invasive FFR measurement were retrospectively analyzed. The CT-derived FFR values were computed using a novel CFD-based model (AccuFFRct, ArteryFlow Technology Co., Ltd., Hangzhou, China). Diagnostic performance of AccuFFRct and CCTA in detecting hemodynamically significant coronary artery disease (CAD) was evaluated using the invasive FFR as a reference standard. Diagnostic accuracy, sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) for AccuFFRct in detecting FFR ≤ 0.8 on per-patient basis were 90.7, 89.5, 91.4, 85.0 and 94.1%, respectively, while those of CCTA were 38.9, 100.0, 5.71, 36.5 and 100.0%, respectively. The correlation between AccuFFRct and FFR was good (r = 0.76 and r = 0.65 on per-patient and per-vessel basis, respectively, both p < 0.0001). Area under the curve (AUC) values of AccuFFRct for identifying ischemia per-patient and per-vessel basis were 0.945 and 0.925, respectively. There was much higher accuracy, specificity and AUC for AccuFFRct compared with CCTA. AccuFFRct computed from CCTA images alone demonstrated high diagnostic performance for detecting lesion-specific ischemia, it showed superior diagnostic power than CCTA and eliminated the risk of invasive tests, which could be an accurate and time-efficient computational tool for diagnosing ischemia and assisting clinical decision-making.

Sections du résumé

BACKGROUND BACKGROUND
Fractional flow reserve (FFR) is a widely used gold standard to evaluate ischemia-causing lesions. A new method of non-invasive approach, termed as AccuFFRct, for calculating FFR based on coronary computed tomography angiography (CCTA) and computational fluid dynamics (CFD) has been proposed. However, its diagnostic accuracy has not been validated.
OBJECTIVES OBJECTIVE
This study sought to present a novel approach for non-invasive computation of FFR and evaluate its diagnostic performance in patients with coronary stenosis.
METHODS METHODS
A total of 54 consecutive patients with 78 vessels from a single center who underwent CCTA and invasive FFR measurement were retrospectively analyzed. The CT-derived FFR values were computed using a novel CFD-based model (AccuFFRct, ArteryFlow Technology Co., Ltd., Hangzhou, China). Diagnostic performance of AccuFFRct and CCTA in detecting hemodynamically significant coronary artery disease (CAD) was evaluated using the invasive FFR as a reference standard.
RESULTS RESULTS
Diagnostic accuracy, sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) for AccuFFRct in detecting FFR ≤ 0.8 on per-patient basis were 90.7, 89.5, 91.4, 85.0 and 94.1%, respectively, while those of CCTA were 38.9, 100.0, 5.71, 36.5 and 100.0%, respectively. The correlation between AccuFFRct and FFR was good (r = 0.76 and r = 0.65 on per-patient and per-vessel basis, respectively, both p < 0.0001). Area under the curve (AUC) values of AccuFFRct for identifying ischemia per-patient and per-vessel basis were 0.945 and 0.925, respectively. There was much higher accuracy, specificity and AUC for AccuFFRct compared with CCTA.
CONCLUSIONS CONCLUSIONS
AccuFFRct computed from CCTA images alone demonstrated high diagnostic performance for detecting lesion-specific ischemia, it showed superior diagnostic power than CCTA and eliminated the risk of invasive tests, which could be an accurate and time-efficient computational tool for diagnosing ischemia and assisting clinical decision-making.

Identifiants

pubmed: 34348731
doi: 10.1186/s12938-021-00914-3
pii: 10.1186/s12938-021-00914-3
pmc: PMC8340407
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

77

Subventions

Organisme : National Natural Science Foundation of China
ID : 81320108003
Organisme : National Natural Science Foundation of China
ID : 31371498
Organisme : National Natural Science Foundation of China
ID : 81100141
Organisme : National Natural Science Foundation of China
ID : 81570322
Organisme : Zhejiang Provincial Public Welfare Technology Research Project
ID : LGF20H020012
Organisme : Zhejiang Provincial key research and development plan
ID : 2020C03016
Organisme : Major projects in Wenzhou of China
ID : ZY2019006
Organisme : Major projects in Jinhua of China
ID : 2020A31003
Organisme : Scientific research project of Zhejiang Education Department
ID : Y201330290

Informations de copyright

© 2021. The Author(s).

Références

Eur Radiol. 2015 Apr;25(4):1201-7
pubmed: 25403173
J Am Coll Cardiol. 2013 Jun 4;61(22):2233-41
pubmed: 23562923
JACC Cardiovasc Imaging. 2017 Jun;10(6):663-673
pubmed: 27771399
N Engl J Med. 2009 Jan 15;360(3):213-24
pubmed: 19144937
J Cardiovasc Comput Tomogr. 2016 Mar-Apr;10(2):105-13
pubmed: 26747231
JACC Cardiovasc Imaging. 2020 Jan;13(1 Pt 1):97-105
pubmed: 31005540
J Am Coll Cardiol. 2010 Jan 19;55(3):173-85
pubmed: 20117397
J Am Coll Cardiol. 2007 Feb 27;49(8):863-71
pubmed: 17320744
Biorheology. 1989;26(6):1011-30
pubmed: 2624892
N Engl J Med. 2012 Sep 13;367(11):991-1001
pubmed: 22924638
Radiology. 2017 Oct;285(1):17-33
pubmed: 28926310
Eur Heart J. 2018 Nov 1;39(41):3701-3711
pubmed: 30165613
JACC Cardiovasc Imaging. 2020 Apr;13(4):980-990
pubmed: 31422138
EuroIntervention. 2012 Feb;7(10):1155-61
pubmed: 22334314
J Am Coll Cardiol. 2014 Apr 1;63(12):1145-1155
pubmed: 24486266
J Am Coll Cardiol. 2010 Mar 9;55(10):957-65
pubmed: 20202511
Clin Cardiol. 2013 Dec;36(12):743-8
pubmed: 24114863
Ann Biomed Eng. 2016 Apr;44(4):1085-96
pubmed: 26101034
Radiology. 2018 Jul;288(1):64-72
pubmed: 29634438
N Engl J Med. 1996 Jun 27;334(26):1703-8
pubmed: 8637515
Eur Heart J. 2015 Dec 14;36(47):3359-67
pubmed: 26330417
J Biomech. 2006;39(11):1983-95
pubmed: 16055134
Radiology. 2015 Mar;274(3):674-83
pubmed: 25322342
J Am Coll Cardiol. 2008 Aug 19;52(8):636-43
pubmed: 18702967
J Am Coll Cardiol. 2019 Jan 22;73(2):161-173
pubmed: 30654888
J Am Coll Cardiol. 2011 Nov 1;58(19):1989-97
pubmed: 22032711
Neural Netw. 2020 Mar;123:82-93
pubmed: 31835156
Eur Heart J. 2013 Oct;34(38):2949-3003
pubmed: 23996286
J Biomech. 2006;39(6):1116-28
pubmed: 16549100
J Appl Physiol (1985). 2016 Jul 1;121(1):42-52
pubmed: 27079692
Circ Cardiovasc Imaging. 2018 Jun;11(6):e007217
pubmed: 29914866
Am J Cardiol. 2014 Nov 1;114(9):1303-8
pubmed: 25205628
JAMA. 2012 Sep 26;308(12):1237-45
pubmed: 22922562

Auteurs

Wenbing Jiang (W)

Department of Cardiology, The Third Clinical Institute Affiliated to Wenzhou Medical University, Wenzhou, China.

Yibin Pan (Y)

Department of Cardiology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.

Yumeng Hu (Y)

ArteryFlow Technology Co., Ltd, Hangzhou, China.

Xiaochang Leng (X)

ArteryFlow Technology Co., Ltd, Hangzhou, China.

Jun Jiang (J)

Department of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, China.

Li Feng (L)

ArteryFlow Technology Co., Ltd, Hangzhou, China.

Yongqing Xia (Y)

ArteryFlow Technology Co., Ltd, Hangzhou, China.

Yong Sun (Y)

Department of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, China.

Jian'an Wang (J)

Department of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, China.

Jianping Xiang (J)

ArteryFlow Technology Co., Ltd, Hangzhou, China.

Changling Li (C)

Department of Cardiology, The Second Affiliated Hospital of Zhejiang University School of Medicine, 88 Jiefang Road, Hangzhou, 310009, China. lichl@edu.zju.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH